Monisha Banerjee

Prof. Dr. Monisha Banerjee


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2012 in Clinica Chimica Acta
Verified
Journal Article
Closed access
MBMonisha Banerjee
Monisha Banerjee
MSMadhukar Saxena
Madhukar Saxena

14 February 2013 in Diabetes
Verified
Journal Article
Open access
PDF file
RTRubina Tabassum
Rubina Tabassum
GCGanesh Chauhan
Ganesh Chauhan
ODOm Prakash Dwivedi
Om Prakash Dwivedi
AMAnubha Mahajan
Anubha Mahajan
AJAlok Jaiswal
Alok Jaiswal
DBDwaipayan Bharadwaj
Dwaipayan Bharadwaj
Indians undergoing socioeconomic and lifestyle transitions will be maximally affected by epidemic of type 2 diabetes (T2D). We conducted a two-stage genome-wide association study of T2D in 12,535 Indians, a less explored but high-risk group. We identified a new type 2 diabetes–associated locus at 2q21, with the lead signal being rs6723108 (odds ratio 1.31; P = 3.32 × 10−9). Imputation analysis refined the signal to rs998451 (odds ratio 1.56; P = 6.3 × 10−12) within TMEM163 that encodes a probable vesicular transporter in nerve terminals. TMEM163 variants also showed association with decreased fasting plasma insulin and homeostatic model assessment of insulin resistance, indicating a plausible effect through impaired insulin secretion. The 2q21 region also harbors RAB3GAP1 and ACMSD; those are involved in neurologic disorders. Forty-nine of 56 previously reported signals showed consistency in direction with similar effect sizes in Indians and previous studies, and 25 of them were also associated (P < 0.05). Known loci and the newly identified 2q21 locus altogether explained 7.65% variance in the risk of T2D in Indians. Our study suggests that common susceptibility variants for T2D are largely the same across populations, but also reveals a population-specific locus and provides further insights into genetic architecture and etiology of T2D.

30 October 2023 in Medicine in Drug Discovery
Verified
Journal Article
Open access
SPShama Parveen
Shama Parveen
PGPratishtha Gupta
Pratishtha Gupta
SKSaurabh Kumar
Saurabh Kumar
MBMonisha Banerjee
Monisha Banerjee

1 January 2009 in Indian Journal of Medical Sciences
Verified
Journal Article
Closed access
MBMonisha Banerjee
Monisha Banerjee
HBHemantKumar Bid
HemantKumar Bid
RKRituraj Konwar
Rituraj Konwar
CACg Aggarwal
Cg Aggarwal
SGSunaina Gautam
Sunaina Gautam
VNVlakshma Nayak
Vlakshma Nayak
The vitamin D receptor (VDR) gene is a candidate gene for susceptibility to several diseases. Studies on association between VDR polymorphisms and risk of type 2 diabetes (T2DM) in different ethnic populations are yet inconclusive. This study was conducted to evaluate association between VDR polymorphisms and genetic susceptibility to T2DM in the north Indian population. One hundred clinically diagnosed T2DM patients and 160 healthy controls from the north Indian population were recruited for genetic association study. Genomic DNA was extracted from blood and genotyped for the single nucleotide polymorphism SNPs of FokI (T/C) [rs2228570], BsmI (A/G) [rs1544410] and TaqI (C/T) [rs731236] by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. Genotype distribution and allelic frequencies were compared between patients and controls. Mean values and odds ratios (ORs) with 95% confidence interval (CI) were calculated using SPSS software (version 15.0). The genotype distribution, allele and haplotype frequencies of VDR polymorphism did not differ significantly between patients and controls. Mean age and waist-hip ratio of patients were found to be associated with VDR polymorphism. Combination studies showed FFBbtt increased the risk of T2DM in north Indians. Our data suggest that VDR gene polymorphism in combination of genotypes is associated with the risk of T2DM and thus requires further studies as a probable genetic risk marker for T2DM.

1 January 2014 in Redox Biology
Verified
Journal Article
Open access
MBMonisha Banerjee
Monisha Banerjee
PVPushpank Vats
Pushpank Vats
Type 2 diabetes mellitus (T2DM), by definition is a heterogeneous, multifactorial, polygenic syndrome which results from insulin receptor dysfunction. It is an outcome of oxidative stress caused by interactions of reactive metabolites (RMs) interactions with lipids, proteins and other mechanisms of human body. Production of RMs mainly superoxide (O2(-)) has been found in a variety of predominating cellular enzyme systems including NAD(P)H oxidase, xanthine oxidase (XO), cyclooxygenase (COX), uncoupled endothelial nitric oxide synthase (eNOS) and myeloperoxidase (MPO). The four main RM related molecular mechanisms are: increased polyol pathway flux; increased advanced glycation end-product (AGE) formation; activation of protein kinase C (PKC) isoforms and increased hexosamine pathway flux which have been implicated in glucose-mediated vascular damage. Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase (GST), nitric oxide synthase (NOS) are antioxidant enzymes involved in scavenging RMs in normal individuals. Functional polymorphisms of these antioxidant enzymes have been reported to be involved in pathogenesis of T2DM individuals. The low levels of antioxidant enzymes or their non-functionality results in excessive RMs which initiate stress related pathways thereby leading to insulin resistance and T2DM. An attempt has been made to review the role of RMs and antioxidant enzymes in oxidative stress resulting in T2DM.

21 September 2013 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MSMadhukar Saxena
Madhukar Saxena
NSNeena Srivastava
Neena Srivastava
MBMonisha Banerjee
Monisha Banerjee